Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
about
Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugsLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaSurface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesLipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy.Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.Role of polymer-drug conjugates in organ-specific delivery systems.Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo.Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.Tannic acid-mediated surface functionalization of polymeric nanoparticlesN-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
P2860
Q26849241-6FBF1D5C-CE73-4E47-AF91-99BECA067F49Q28068437-39E62282-1C92-44F7-AC79-C67B8A9E855EQ28071773-7E2958B4-3F54-4335-8442-8F42EFA72221Q38007182-9DC77695-6F99-45CC-A969-AA02E66EBBD6Q38271422-29762165-64BA-4371-99C5-F93D1B65D511Q38365556-E8702AEA-37C3-4C7B-849B-D071CA9B1822Q39032031-B14F0B68-0DD5-4E2A-8023-206EC42E6147Q39144516-C811F59E-FCCB-4218-B253-896037DBD9D9Q39386696-2626993B-10A0-4F79-92BB-563F33959286Q41697936-4ECA3906-7C98-4C39-BB0E-94D05ABA35D5Q46700387-74E25EC6-B418-4F6B-966C-07AC7C7BB93AQ47097596-BECED765-F3A6-46C8-AFA6-136DC84D6830Q51109699-7C46EF82-314A-4CEA-86BF-2CED3A68DD64
P2860
Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Effect of octreotide-polyethylene glycol
@nl
Effect of octreotide-polyethyl ...... ded with hydroxycamptothecine.
@en
type
label
Effect of octreotide-polyethylene glycol
@nl
Effect of octreotide-polyethyl ...... ded with hydroxycamptothecine.
@en
prefLabel
Effect of octreotide-polyethylene glycol
@nl
Effect of octreotide-polyethyl ...... ded with hydroxycamptothecine.
@en
P2093
P356
P1476
Effect of octreotide-polyethyl ...... ded with hydroxycamptothecine.
@en
P2093
Aiwen Huang
Dongfen Yuan
Jiangxiu Niu
Minjie Sun
Qineng Ping
Weiliang You
Xiaoye Sang
Yanyu Xiao
P304
P356
10.1021/MP100463N
P407
P577
2011-08-16T00:00:00Z